Following the sharing of experience in the field, and in view of the very rapid development of innovative therapies, Belgian clinicians have drawn up national recommendations for the management of patients suffering from myasthenia gravis :
- these recommendations were drawn up in February 2024 and cover both generalised myasthenia and ocular myasthenia,
- they take into account current prescribing practices,
- they take into account current prescribing practices and also address other aspects of management, such as co-morbidities, the list of contraindicated drugs, pregnancy and vaccinations.
